|Podcasts|September 3, 2020
Episode 64: The Complexities of Managing ADHD
Author(s)Elaine Quilici
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
Advertisement
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Ambition to Advantage: How Life Sciences Leaders Are Scaling AI
2
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
3
EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%
4
Augmentin XR Becomes First Approval Under Commissioner’s National Priority Voucher Pilot Program
5
